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Hypoxia is one of the main insults in proliferative retinopathies, leading to
neovascularization and neurodegeneration. To maintain homeostasis, neurons require
efficient degradation and recycling systems. Autophagy participates in retinal cell death,
but it is also a cell survival mechanism. Here, we analyzed the role of autophagy at the
three characteristic time periods in the oxygen-induced retinopathy (OIR) mouse model
and determined if its modulation can improve vascular and non-vascular alterations.
Experiments were performed with chloroquine (CQ) in order to monitor autophagosome
accumulation by lysosomal blockade. Post natal day (P)17 OIR mouse retinas showed
a significant increase in autophagy flux. In particular, an intense LC3B and p62 staining
was observed in inner layers of the retina, mainly proliferating endothelial cells. After a
single intraocular injection of Rapamycin at P12 OIR, a decreased neovascular area
and vascular endothelial growth factor (VEGF) protein expression were observed at
P17 OIR. In addition, whereas the increased expression of glial fibrillary acidic protein
(GFAP) was reversed at P26 OIR, the functional alterations persisted. Using a similar
therapeutic schedule, we analyzed the effect of anti-VEGF therapy on autophagy flux.
Like Rapamycin, VEGF inhibitor treatment not only reduced the amount of neovascular
tufts, but also activated autophagy flux at P17 OIR, mainly in ganglion cell layer and
inner nuclear layer. Finally, the effects of the disruption of autophagy by Spautin-1, were
evaluated at vascular, glial, and neuronal levels. After a single dose of Spautin-1, Western
blot analysis showed a significant decrease in LC3B II and p62 protein expression at P13
OIR, returning both autophagy markers to OIR control levels at P17. In addition, neither
gliosis nor functional alterations were attenuated. In line with these results, TUNEL
staining showed a slight increase in the number of positive cells in the outer nuclear
layer at P17 OIR. Overall, our results demonstrate that all treatments of induction or
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inhibition of the autophagic flux reduced neovascular area but were unable to completely
reverse the neuronal damage. Besides, compared to current treatments, rapamycin
provides a more promising therapeutic strategy as it reduces both neovascular tufts
and persistent gliosis.
Keywords: autophagy, hypoxia, proliferative retinopathies, vascular endothelial growth factor, retinal
functionality, gliosis, neurodegeneration
INTRODUCTION
Retinal neovascular pathologies are still leading causes of
blindness worldwide in middle age (DR) and pediatric
[retinopathy of prematurity (ROP)] population (Campochiaro,
2015; Rubio and Adamis, 2016). Currently, there is a wide
spectrum of treatments available for these diseases including laser
photocoagulation and, more recently the intraocular injections
of anti-VEGF agents (Evans et al., 2014; Diabetic Retinopathy
Clinical Research Network et al., 2015; Tah et al., 2015).
Independently of the etiology, retinal neovascular pathologies
are characterized by an increase in cytoplasmic HIF-1α levels, a
subsequent dimerization with HIF-1β and translocation to the
nucleus (Semenza, 2012). Vascular endothelial growth factor is
one of the most critical target genes of HIF, and a well-known
key player in neovascularization (NV) (Nagy et al., 2008). This
trophic factor has pleiotropic functions over neurons and ECs in
health and disease (Saint-Geniez et al., 2008; Zhang et al., 2009).
In hypoxic environment VEGF levels largely increase and is the
main responsible of ECs survival, migration, and proliferation
(Gerhardt, 2008). Nowadays, anti-VEGF therapies are the most
recommended treatment for retinal NV as they have proved high
efficacy in animal models and clinical trials (Tah et al., 2015).
Although anti-VEGF treatment has shown better outcomes
than alternative treatments, ophthalmologists have detected
unequal response of patients to the same administration scheme.
Moreover, they have observed that some patients lost visual
acuity after the chronic treatment (Osaadon et al., 2014; Yang
et al., 2016). There are two main explanations that shed light
on these events. On one hand, other proteins involved in NV,
inflammation, vascular tone and metabolism have critical roles,
whereby, VEGF inhibition would result insufficient to restore
retinal homeostasis and regresses NV in the hypoxic milieu. On
the other hand, VEGF is also a neuroprotective factor and its
further depletion has deleterious effects over neuronal survival.
Consequently, many researchers have designed new
pharmacological strategies to cope with NV through the
modulation of different proteins or molecular pathways.
Based on multiple studies carried out in the field of cancer
angiogenesis, recently, it has been proposed that autophagy
Abbreviations: CQ, chloroquine; DR, diabetic retinopathy; ECs, endothelial cells;
ERG, electroretinogram; GCL, ganglion cell layer; GFAP, glial fibrilar acid protein;
GS, glutamine synthase; HIF, hypoxia inducible factor; ILM, inner limitant
membrane; INL, inner nuclear layer; LAMP1, lysosomal-associated membrane
protein 1; LC3B, microtubule-associated proteins 1A/1B light chain 3B; MGCs,
Muller glial cells; NG-2, neuron-glial 2; NV, neovascularization; OIR, oxygen
induced retinopathy; ONL, outer nuclear layer; P, post natal day; RA, room air;
ROP, retinopathy of prematurity; VEGF, vascular endothelial growth factor; VO,
vaso-obliteration.
flux would have an important role as a potential therapeutic
tool in clinical medicine (Mizushima and Komatsu, 2011).
Autophagy is a catabolic intracellular mechanism that provides
recycling of its components through the engulfment of
damaged proteins and organelles in a double membrane vesicle
(Levine et al., 2015). As it participates in retinal cell death but
it is also a cell survival mechanism, its modulation may be
either beneficial or deleterious depending on the retinal cell type
involved or the disease context (Boya et al., 2016; Chai et al.,
2016; Rosa et al., 2016; Amato et al., 2018). In this work, we
intend to unravel the role of autophagy on retinal pathological
NV and neurodegeneration in mice with oxygen-induced
retinopathy (OIR), an animal model of proliferative ischemic
retinopathy, and determine if its modulation can improve retinal
functionality, gliosis, and avoid neuronal cell death.
MATERIALS AND METHODS
C57BL/6J mice were handled according to guidelines of the
ARVO Statement for the Use of Animals in Ophthalmic and
Vision Research. Experimental procedures were designed and
approved by the Institutional Animal Care and Use Committee
(CICUAL) of the Faculty of Chemical Sciences, National
University of Córdoba (Res. HCD 1216/18). All efforts were made
to reduce the number of animals used.
Oxygen-Induced Retinopathy (OIR)
Mouse Model
In the OIR mouse model (Smith et al., 1994), litters of
mice pups and their mothers were exposed to high oxygen
concentration (75 ± 2%) from P7 to P12 (hyperoxic period)
in an incubator chamber. Oxygen was checked twice daily with
an oxygen analyzer (Teledyne Analytical Instruments, Industry,
CA, United States). Then, mice were brought to room air (RA)
for additional 5 or 14 days. Age-matched control C57BL/6 mice
were kept continuously at RA. Animals were maintained in
clear plastic cages with standard light cycles (12 h light/12 h
dark). At P12, OIR mice were intravitreally injected with a
1.0 µl of solution containing a specific treatment: (a) Rapamycin:
0.5 µg/ml (R0395 Sigma Aldrich, St. Louis, MO, United States);
(b) Anti-VEGF mAb: 1.25 µg anti-VEGF diluted 1/20 with
phosphate buffered saline (PBS) (Bevacizumab; Genentech,
San Francisco, CA, United States) as previously reported (Ridano
et al., 2017); (c) Spautin-1 200 µM (SML0440, Sigma Aldrich,
St. Louis, MO, United States). Vehicle (DMSO/PBS or PBS)/-
injected mice were used as controls. Rapamycin and Spautin-
1 concentrations were selected according to in vitro assays
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(Chen et al., 2014; Russo et al., 2018) and concentrations 10 folds
higher than in cell cultures were used (taking in account the
dilution of the drug in the vitreous cavity). Briefly, pups were
locally anesthetized with one drop of proparacaine hydrochloride
0.5% (Anestalcon, Alcon), exophthalmia was induced with one
drop of tropicamide 1% (Midril, Alcon, Buenos Aires, Argentina)
and eyes were injected at the upper nasal limbus as described
previously (Barcelona et al., 2011). Some mice were sacrificed
at three typical times in the OIR mouse model: P12 (maximum
vaso-obliteration, VO), P17 (maximum NV) and P26 (vascular
alteration resolution) (Smith et al., 1994). To evaluate the effect
of Rapamycin or Spautin-1 mice were sacrificed 24 h after the
injection (P13). In order to analyze the autophagy flux, some
mice received an intraperitoneal (i.p.) injection of chloroquine
(CQ) 60 mg/kg (Sigma Aldrich, St. Louis, MO, United States)
diluted in sterile PBS 4 h before sacrifice. Eyes or retinas
of sacrificed mice with CQ pre-treatment were collected and
processed for Western blot and immunofluorescence assays and
without CQ pre-treatment for quantitative real-time PCR (qRT-
PCR), immunohistochemistry, or flat-mount assays. At least six
mice per group were used for each condition at each survival time
examined. Data were collected from both males and females as
there were no apparent sex differences. All mice were sacrificed
at the same time of day in order to avoid the circadian effects and
to reduce the mouse-to-mouse variability in autophagy markers
and flux. Lysosomal analyses were carried out with intraocular
injection of 1 µl of red DQ-BSA (1 mg/ml dissolved in PBS
pH 7.2; D12051, Invitrogen). The reagent is taken up by every
cell and then the red dye is detected in acidic compartments,
where DQ is hydrolyzed from albumin. Mice were sacrificed 4 h
after DQ injection (without CQ pre-treatment), fixed with 4%
paraformaldehyde (PFA) and dehydrated by sucrose gradient for
further cryosection.
Electroretinography (ERG)
Electroretinographic activity was assessed as previously described
(Ridano et al., 2017). Briefly, after overnight (ON) dark
adaptation and under dim red illumination, mice were
anesthetized via i.p. injections with a solution containing
ketamine (90 mg/kg)/xilacine (8 mg/kg). The pupils were dilated
with 1% tropicamide and the cornea was lubricated with gel
drops of 0.4% polyethyleneglycol 400 and 0.3% propylene glycol
(Systane, Alcon, Buenos Aires, Argentina) to prevent damage.
Mice were exposed to stimuli at a distance of 20 cm. A reference
electrode was inserted on the back in the neck, a grounding
electrode was attached to the tail, and a gold electrode was
placed in contact with the central cornea. Electroretinograms
were simultaneously recorded from both eyes and 10 responses
to flashes of unattenuated white light (5 cd.s/m2, 0.2 Hz) from
a photic stimulator (light-emitting diodes) set at maximum
brightness were amplified, filtered (1.5-Hz low-pass filter, 1000
high-pass filter, notch activated) and averaged (Akonic BIO-PC,
Argentina). The a-wave was measured as the difference in
amplitude between the recording at onset and trough of the
negative deflection, and the b-wave amplitude was measured
from the trough of the a-wave to the peak of the b-wave. The
latencies of the a- and b-waves were measured from the time of
flash presentation to the trough of the a-wave or the peak of the
b-wave, respectively. Responses were averaged across the two
eyes for each mouse.
Labeling of Flat-Mount Retinas
Mice were euthanized at P17 and eyes were enucleated and fixed
with freshly prepared 4% PFA for 1–2 h at room temperature
(RT). Corneas were removed with scissors along the limbus
and the whole retinas were dissected. Then, they were blocked
and permeabilized in Tris-buffered saline (TBS) containing 5%
Bovine Serum Albumin (BSA) and 0.1% Triton-X-100 during6 h
at 4◦C. After that, retinas were incubated ON with 0.01 µg/µl
of Isolectin IB4 Alexa fluor-488 conjugate (GSA-IB4) from
Molecular Probes, Inc. (Eugene, OR, United States) and anti-
GFAP (1/200; Dako, Carpinteria, CA, United States) or anti-
microtubule-associated protein-1 light-chain 3 (LC3) B (1:100;
L7543, Sigma). Retinas were then washed with TBS containing
0.1% Triton-X-100, stored in PBS at 4◦C and examined
by confocal laser-scanning microscopy (Olympus FluoView
FV1200; Olympus, Corp., New York, NY, United States).
Retinal Cryosection, Protein Extract, and
RNA Sample Preparation
For cryosection, enucleated eyes were fixed during 2 h with
4% PFA at RT, and incubated ON in 10, 20, and 30%
of sucrose in PBS at 4◦C. Then, they were embedded in
optimum cutting temperature (OCT) (Tissue-TEK, Sakura)
compound, and 10 µm-thick radial sections were obtained by
using a cryostat, as described (Sanchez et al., 2006). Retinal
cryosections were stored at −20◦C under dry conditions until
immunohistochemical analysis.
Neural retinas were dissected from RPE/choroid layers for
Western blot and qRT-PCR analysis. Protein extracts were
obtained from retinas after homogenization with a lysis buffer
containing 20 mM Tris-HCl pH 7.5, 137 mM NaCl, 2 mM
EDTA pH 8, 1% Nonidet P40, 1 mM phenylmethylsulfonyl
fluoride (PMSF), 2 mM sodium ortovanadate and protease
inhibitor cocktail (Sigma Aldrich, St. Louis, MO, United States)
(Sanchez et al., 2006), and were sonicated during 20 s at 40%
amplitude. In addition, some neural retinas were disrupted in
500 µL Trizol (Invitrogen) and were stored at −80◦C until RNA
extraction. All the assays were performed in triplicate and results
are representative of at least three independent experiments
(animals in each group).
Immunofluorescence
Immunostaining was performed as described previously (Ridano
et al., 2017). Briefly, mouse cryosections were washed in PBS,
blocked with 2% of BSA in PBS containing 0.1% Tween-20, for
1 h and then incubated ON at 4◦C with the following primary
antibodies, respectively: rabbit polyclonal anti-LC3B (1/100;
L7543, Sigma Aldrich), mouse monoclonal anti-p62 (1/100;
ab56416, Abcam), rabbit polyclonal anti- GS (1/100; ab16802,
Abcam), rat monoclonal anti- LAMP1 (1/350; ab25245, Abcam),
mouse monoclonal anti- GS (1/100; MAB 302, Millipore), mouse
monoclonal anti-CD31 (1/50; Abcam, Inc., Cambridge, MA,
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United States) and rabbit polyclonal anti-NG-2 (1/100; AB5320,
Millipore). Then, sections were washed with TBS 0.1% Triton-
X-100 and incubated with secondary antibodies including goat
against rabbit or mouse IgG conjugated with Alexa Fluor 488
and 594 (1/250; Molecular Probes, Eugene, OR, United States)
and goat anti rat IgG conjugated with Alexa Fluor 594 (1/200;
ab150160, Abcam), during 1 h at RT. The sections were also
counterstained with Hoechst 33258 (1:3000; Molecular Probes)
for 7 min. After a thorough rinse, the sections were mounted
with Fluor Save (Calbiochem, La Jolla, CA, United States) and
cover slipped. The labeling was visualized using a confocal
laser-scanning microscope (Olympus Fluvial FV300 or FV1200;
Olympus, Corp., New York, NY, United States). Finally,
images were processed with Image J 2 software (National
Institutes of Health, Bethesda, MD, United States), including
spatial deconvolution, vesicle quantification and colocalization.
Negative controls without incubation with primary antibody
were carried out to detect unspecific staining (data not shown).
Western Blot
Protein concentration of retinal extracts were determined by
a BCA kit (Pierce, Buenos Aires, Argentina) and 10–20 µg
of proteins were electrophoresed in 15% SDS-PAGE. After
electrophoresis, proteins were transferred to nitrocellulose
membranes (Amersham Hybond ECL; GE Healthcare Bio-
Sciences AB, Uppsala, Sweden). To prevent non-specific binding,
membranes were blocked with 5% milk in TBS containing 0.1%
Tween-20 (TBST) during at least 1 h at RT. Then, blots were
incubated with primary antibodies diluted in TBST or 5% BSA
in TBST for 1 h at RT or overnight at 4◦C, according to the
antibody. The following antibodies were used: rabbit polyclonal
anti-LC3 (1/1000; L7543, Sigma Aldrich), mouse monoclonal anti
p62 (1/1000; ab56416, Abcam) mouse monoclonal anti- VEGF
(1/500; R&D system), rabbit polyclonal anti-GFAP (1/1000;
Dako, Carpinteria, CA, United States), mouse monoclonal anti-
GS (1/500; MAB 302, Millipore Corporation MA, United States),
rabbit polyclonal anti-caspase 3 (1/300; HPA 002643, Sigma
Aldrich) and mouse monoclonal anti-β-actin (1/2000; ab8226,
Abcam). Blots were incubated with IRDye 800 CW donkey
anti-rabbit Ig, or IRDye 800 CW donkey anti-mouse IgG
antibodies (1/15000 in TBS with 5% BSA) for 1 h, protected from
light. After washing with TBST, membranes were visualized and
quantified using the Odyssey Infrared Imaging System (LI-COR,
Inc., Lincoln, NE, United States).
Quantitative Real-Time Polymerase
Chain Reaction
Total RNA was extracted from neural retinas using Trizol
(Invitrogen), according to the manufacturer’s instructions and
was processed as previously reported (Ridano et al., 2017).
Briefly, 1 µg of total RNA was reverse-transcribed in a total
volume of 20 µl using random primers (Invitrogen, Buenos
Aires, Argentina) and 50 U of M-MLV reverse transcriptase
(Promega, Corp.). Then, cDNA was mixed with 1x SYBR Green
PCR Master Mix (Applied Biosystems) and forward and reverse
primers: Beclin1 forward: ATGGAGGGGTCTAAGGCGTC/
Beclin 1 reverse: TGGGCTGTGGTAAGTAATGGA; ATG5
forward: TGTGCTTCGAGATGTGTGGTT/ ATG5 reverse:
GTCAAATAGCTGACTCTTGGCAA; MAPLC3 forward:
CGCTTGCAGCTCAATGCTAAC/ MAPLC3 reverse: TCG
TACACTTCGGAGATGGG; P62 forward: TGTGGAACAT
GGAGGGAAGAG/ P62 reverse: TGTGCCTGTGCTGGAA
CTTTC. qPCR were carried out on an Applied Biosystems
7500 Real-Time PCR System with Sequence Detection
Software v1.4. The cycling conditions included a hot
start at 95◦C for 10 min, followed by 40 cycles at 95◦C
for 15 s and 60◦C for 1 min. Specificity was verified
by melting curve analysis. Results were normalized to
β-actin (Forward: GGCTGTATTCCCCTCCATCG/ Reverse:
CCAGTTGGTAACAATGCCATGT). Relative gene expression
was calculated according to the 2-11Ct method. Each sample
was analyzed in triplicate. No amplification was observed in
PCRs using as template water during the cDNA synthesis
(data not shown).
TUNEL Assay
Cell death was examined by terminal deoxynucleotidyltransferase
biotin dUTP nick end labeling (TUNEL) assay (Roche,
Mannheim, Germany), which contain an anti-dUTP antibody
labeled with peroxidase (POD), according to manufacturer’s
instructions. Slides were counterstained with methyl green to
visualize total nuclei and then mounted with DPX Mounting
Media (Sigma Aldrich, St. Louis, MO, United States). Negative
controls without enzyme were processed in order to avoid false
positive results (data not shown). Images were obtained under a
light microscope (Nikon Eclipse TE2000-E, United States).
Statistical Analysis
Statistical analysis was performed using the GraphPad Prism 5.0
software. A p-value < 0.05 was considered statistically significant.
Parametric or non-parametric tests were used according to
variance homogeneity evaluated by F or Barlett’s tests. Two-
tailed unpaired t or Mann–Whitney tests were used in analysis
of two groups. One-way analysis of variance (ANOVA) followed
by Dunnett´s multiple comparison post-test or Kruskal–Wallis
followed by Dunn’s multiple comparison post-test were used to
determine statistical significance among more than two different
groups. Two-way ANOVA followed by Bonferroni post-test was
used in comparisons between groups when two variables were
affecting the dependent variable. Mean ± standard error (SEM)
are shown in graphs analyzed with parametric tests and median
with interquartile range are shown when data were analyzed with
non-parametric test.
RESULTS
Hypoxia Induced Autophagy During
Neovascular Stage in the OIR Mouse
Model
Autophagy is a strictly regulated process that plays a vital role
in cell growth, transition, and death (Kimura et al., 2017). In
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the nervous system it is a matter of intense investigation as
these pathways are often missregulated during neovascular and
neurodegenerative conditions (Harris and Rubinsztein, 2011;
Du et al., 2012; Liu et al., 2016). In this regard, the mouse model
of OIR offers an opportunity to examine the role of hypoxia in
the pathogenesis of retinal NV, neuroinflammation, oxidative
stress, and neurovascular cross-talk (Kim et al., 2016). Thus, in
order to study autophagy flux, we determined the expression of
classical autophagy markers at the three relevant time points in
the OIR mouse model (Figure 1A). As we expected, GSA-IB4
lectin-labeled blood vessels in flat-mount retinas showed, at
P17 OIR, a central zone of VO in addition to the characteristic
vitreoretinal neovascular tufts, which were not observed in P17
RA controls (Figure 1B). Post-mitotic cells, especially neurons,
are highly dependent on intracellular degradation systems
because they provide adequate waste products elimination. The
retina is known to have a fast autophagy flux due to the constant
exposure to light and increased production of reactive oxygen
species (Trachsel-Moncho et al., 2018). Therefore, we decided to
block the autophagosome fusion with lysosomes and degradation
with an i.p. injection of CQ to evaluate the accumulation of
autophagosomes. Retinal levels for LC3B and p62 protein
expression, at each temporal point, were measured in both RA
and OIR mice by Western blot assays (Figure 1C). Quantitative
analysis revealed a slight increase in LC3B II protein expression
level at P12 in OIR mice, which was markedly upregulated in
P17, returning to baseline levels at P26. In our experimental
conditions, upregulation of LC3B II in retinal extracts at P17
OIR was associated with an increase, although not statistically
significant, in p62 protein expression (Figure 1D). To gain
more insight into autophagy regulation at the time point where
most changes have been observed (P17), additional Western
blot assays in mice injected with vehicle or CQ were performed
(Figure 1E). Quantitative analysis showed an increase, although
not statistically significant, in both LC3B II and p62 levels at P17
OIR compared to RA mice retinas injected with vehicle, which
were further enhanced after CQ treatment (Figure 1F). Our data
showed that the augmentation of LC3B II by hypoxic injury is
due to the enhancement of autophagic flux rather than impaired
clearance of autophagosomes.
Next, we examined the transcript expression of molecules
involved in nucleation (Beclin-1), elongation (ATG-5), and
structure (LC3) of the autophagosome (Yin et al., 2016), and also
the autophagy substrate p62 at the peak of NV. Beclin-1, ATG-5
and LC3 mRNA levels did not showed changes at P17, whereas
expression of p62 mRNA was increased ∼1.8−fold at this time
point (Figure 1G).
By immunostaining of retinal cryosections we confirmed
the increase in LC3B and p62 protein expression at P17 OIR
(Figure 1H). Given that there is a tissue gradient of hypoxia
in OIR retinas (Rodrigues et al., 2013), we decided to evaluate
whether variations in autophagy flux were similar in every retinal
layer. The analysis revealed an intense LC3B and p62 signal in
the inner limiting membrane (ILM) at P17 OIR (Figure 1I). As
neurons in the INL and GCL are severely affected by hypoxia
(Ridano et al., 2017), quantification evidenced an increase in
LC3B puncta mainly in these areas. At the same time, no
modification in the autophagy marker puncta was observed in the
ONL (Figures 1I,J).
Finally, we explored in more detail the presence of
autophagosomes in the ILM, a region where vascular and
macroglial cells actively interact. In cryosections, we identified
Müller glial cells (MGCs) and vascular cells by staining with
GS and CD31 respectively, whereas in retinal flat-mounts ECs
were isolectin IB4+ cells (Figure 2, upper panel). Both macroglial
and ECs showed, at P17 OIR, a slight increase in LC3B vesicles
within the cells (Figures 2A,B). However, in neovascular tufts,
ECs showed the great number of autophagic vesicles (Figure 2C).
In order to determine if the degradative pathway is activated
at P17 OIR, we performed immunofluorescence assays using a
combination of LC3B antibody along with the late endosomal
compartments and lysosomes marker LAMP1 antibody
(Figure 2D). Fusion of LC3B and LAMP1 positive vesicles was
observed in ILM, GCL, and INL in OIR and RA neural retinas
(Figure 2E). Our statistical analysis did not found differences in
colocalization quantification in absence of CQ, probably due to
the fast flux in the retina (Figure 2F). Through the injection of
CQ, we could detect an increase of LAMP-1 vesicles, suggesting
that lysosomes and late endosomes are following the degradation
pathway properly (Figures 2G,H). To further examine the
lysosomal activity, mice were intravitreally injected with bovine
serum albumin derivate DQ-BSA (Frost et al., 2017). Confocal
images showed an increased DQ-BSA staining in ECs at the time
when the NV peaks in the OIR mice, compared to RA control
retinas (Figure 2I), correlating with the observed in Figure 2E.
However, this increase was not observed in the retinal layers
where death was increased (Figure 2I). Collectively, our results
showed an increase in autophagy flux mainly in proliferating ECs,
and inner layers of the retina whereas neurons from the ONL did
not showed modifications in autophagic flux at P17 OIR.
Rapamycin Promoted Autophagy,
Prevented NV and Improved Gliosis in
the OIR Mice Model
Rapamycin is a potent inhibitor of the complex mTORC1. One
of the functions of this multi-protein complex is to prevent
the formation of new autophagosomes by phosphorylation of
ATG13. In this sense, Rapamycin acts as an autophagy inductor
and its different pharmacological formulations (everolimus,
sirolimus, among others) have shown beneficial effects in cancer
therapies (Li et al., 2014). On the other hand, mTORC1
phosphorylation increase VEGF synthesis, a trophic factor
required for vessel survival, proliferation and migration (Wei
et al., 2016). New insights in retinal neurodegeneration pointed
Rapamycin as a promising therapy as it could both activate
autophagy and decrease angiogenesis (Zhu and Du, 2018). Hence,
we decided to evaluate neovascular and neurodegenerative
processes in the OIR mouse model after Rapamycin treatment
(Figure 3A). After a single intraocular injection at P12
OIR, we verified the increase in the autophagy flux 24 h
later by Western blot assay (Figure 3B). In addition, as
Yagasaki et al. (2014) demonstrated previously, Rapamycin
decreased the NV in P17 OIR retinas. Quantitative analysis
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FIGURE 1 | Continued
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FIGURE 1 | Effect of hypoxia on the autophagic flux during NV and neurodegeneration in OIR mouse retinas. (A) Scheme representing the OIR mouse model with
hallmark time points during experimental disease development. Neonatal mice and their nursing mother are kept in room air from birth to P7. At P7, they are
exposed to 75% oxygen, which inhibits retinal vessel growth and causes significant VO. Mice are returned to RA at P12; the avascular retina becomes hypoxic,
eliciting both normal vessel regrowth and pathological neovascular response. NV reaches its maximum at P17. Shortly thereafter, it spontaneously regresses and the
vascular alterations resolve by P25. (B) Representative images of flat-mount retinas at P17 showing GSA-IB4 vascular staining in RA and OIR mice. Areas with VO
and NV are indicated. Scale bar: 500 µm. (C,D) Representative Western blot and quantification data of autophagy markers LC3B II and p62 from neural retinal
extracts of RA and OIR at P12, P17, and P26. Mice were injected i.p. with CQ 4 h before sacrifice. β-Actin is shown as a loading control. Graph shows results of
three independent experiments. (E,F) Representative Western blot and quantification data of autophagy markers, LC3B II and p62, from neural retinal samples of RA
and OIR mice injected with vehicle or CQ at P17, and evaluated 4 h after administration. β-Actin is shown as a loading control. Graph shows results of three
independent experiments. (G) Beclin-1, ATG5, LC3, and p62 mRNA levels were quantified by qRT-PCR in neurosensory retinas of P17 OIR and RA mice. Results
were normalized to β-actin and expressed according to the 2-11Ct method using as calibrator the mRNA level obtained from P17 RA mouse retinas.
(H) Representative immunofluorescence analysis of LC3B (green) and p62 (red) in cryosections of RA and OIR mice injected with CQ at P12, P17, or P26 and
evaluated 4 h after administration. Cell nuclei were counterstained with Hoechst 33258 (blue). (I) Representative labeling of LC3B (green) in cryosections of RA and
OIR mouse retinas at P17, 4 h after CQ administration. Images were taken with oil 60X objective in the best confocal resolution condition. Cell nuclei were
counterstained with Hoechst 33258 (blue) Scale bar: 5 µm. (J) Quantification of LC3B puncta per area or cell with ImageJ analyze particles software. ILM, inner
limiting membrane; GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer. Data are
presented as mean ± SEM. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
revealed a decrease of more than 75% of retinal NV area.
However, the treatment was not able to attenuate other
vascular alterations as avascular area, vessel dilatation and
tortuosity (Figures 3C,D). In line with these observations,
our next goal was to determine the protein expression
levels of VEGF after Rapamycin treatment. Our results
demonstrate that Rapamycin injection at P12 OIR significantly
reduced VEGF protein expression in P17, respect to vehicle-
injected OIR mouse samples (Figure 3E). Pericytes are
mesenchymal cells that make important contributions to the
microvascular tree in both normal and pathologic tissues
(Gerhardt and Betsholtz, 2003). To determine the effect of
Rapamycin on pericytes, retinal cryosections at P17 OIR were
analyzed by immunofluorescence assay. Confocal microscopy
analysis revealed no significant changes in NG-2 (a pericyte
marker) staining after Rapamycin injection at P12 among both
conditions (Figure 3F).
Persistent glial activation is considered a bad prognosis sign,
as macroglial reactive cells frequently secrete cytokines and
chemokines, contributing to the proinflammatory environment
and mediating neuronal death (Subirada et al., 2018). Recently,
we have demonstrated that P17 OIR mouse retinas showed
the highest neovascular profile and exhibited neuro-glial injury
as well as retinal functional loss, which persisted until P26
OIR (Ridano et al., 2017). Herein, we further analyzed if
the inhibition of mTORC1 improved gliosis. By Western blot
assays we observed comparable protein expression of GFAP in
Rapamycin and vehicle-injected P17 OIR retinas (Figures 4A,B),
which was corroborated by confocal microscopy analysis of
flat mounts retinas (Figure 4C). However, the quantification
at P26 evidenced a significant decrease of the GFAP protein
expression after Rapamycin injection at P12. At the same time,
we evaluated glial ability to prevent excitotoxicity by analyzing
GS protein expression. Quantification of protein levels of the
detoxifying enzyme indicated that it was not modified after
Rapamycin treatment neither at P17 nor at P26 (Figures 4A,B),
although a slight increase in the inner layers was detected by
immunofluorescence staining (Figure 4D).
In retinal neovascular pathologies there is a direct
relationship between vascular changes and neuronal
dysfunction (Kern, 2014). Thus, we performed ERG
studies in both OIR groups (vehicle and Rapamycin)
and recorded the intensity (amplitude) and the speed
(latency) of the neuronal response after light stimuli. Results
demonstrated that neurodegeneration associated to NV
was not prevented by the injection at P12 of Rapamycin
as ERG signals at P17 and P26 did not show differences
after treatment (Figure 4E). In line with this result, TUNEL
assay (Figure 4F) and Western blot quantification of total
caspase-3, in retinal extracts of OIR mice (Figures 4G,H),
were similar in Rapamycin-injected respect to vehicle-injected
OIR mouse samples.
We also evaluated changes in autophagy flux at P17 and P26
OIR after Rapamycin treatment. As shown in Figures 4G,H,
increased levels of LC3B II and p62 expression persisted up to
P17. Immunofluorescence assays (Figure 4I), were consistent
with the Western blot results demonstrating LC3B and p62
staining mainly at GCL and INL. Together, these results indicate
that a single injection of Rapamycin was able to prevent the
formation of neovessels at P17 OIR by decreasing VEGF protein
expression and ameliorate gliosis at P26. By contrast, other
vascular and neuronal abnormalities were not reverted.
Anti-VEGF Treatment Increased the
Autophagy Flux in OIR Mouse Retinas
In recent years, several studies have shown that VEGF
inhibitors can lead to the activation of autophagy, including
ranibizumab, bevacizumab, and several other vascular
inhibitors (Liang et al., 2015; Lytvynchuk et al., 2015; Liu
et al., 2016). Thus, we decided to determine whether the
classical anti-angiogenic treatment was able to modulate the
autophagic flux. For this purpose, using a similar treatment
schedule (Figure 5A), we verified the anti-VEGF effect on
vascular alteration in flat-mount retinas, where a significant
reduction in neovascular and avascular areas was observed
(Figure 5B). In addition, as expected, the administration of
anti-VEGF mAb at P12 significantly reduced VEGF protein
expression in P17 respect to vehicle-injected OIR mouse
samples (Figures 5C,D).
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FIGURE 2 | Continued
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FIGURE 2 | Effect of hypoxia on LC3B expression and distribution in P17 mouse retinas. Double labeling using: (A) a mouse monoclonal antibody for LC3B (red)
and a MGC marker, anti-GS (green). Representative merged fluorescence confocal images of entire z-stack (XY) with orthogonal views, XZ and YZ of a mouse retina.
Arrows are indicating autophagosomes in MGCs. Scale bar: 5 µm; (B) a mouse monoclonal antibody for LC3B (green) and an EC-specific marker, anti-CD31 (red).
Cell nuclei were counterstained with Hoechst 33258 (blue). Arrows are indicating autophagosomes in ECs. Scale bar: 50 µm. (C) High magnification confocal
micrograph of the representative P17 OIR retina showing a typical neovascular tuft (GSA-IB4, green) staining with LC3B (red). Images were taken with oil 60X
objective in the best confocal resolution condition. Representative merged fluorescence confocal images of entire z-stack (XY) with orthogonal views, XZ and YZ.
Scale bar: 15 µm (D) Representative immunofluorescence analysis of LAMP1 (red) and LC3B (green) in cryosections of P17 RA and OIR mice. Scale bar: 50 µm.
(E) Representative immunofluorescence analysis of LAMP1 (red) and LC3B (green) in cryosections of P17 RA and OIR mice. Images were taken with oil 60X
objective and zoom 5x in the best confocal resolution condition. Cell nuclei were counterstained with Hoechst 33258 (blue) Scale bar: 5 µm. (F) Quantification of
LC3B/LAMP1 vesicles per area (ILM) or cell (GCL and INL) with ImageJ JACoP software. Pearson values were compared statistically. Statistical t-test was
performed. (G) Representative immunofluorescence analysis of LAMP1 (red) in cryosections of RA and OIR mice injected with CQ at P17, and evaluated 4 h after
administration. Scale bar: 50 µm. (H) Quantification of LAMP1 puncta per area or cell with ImageJ analyze particles software. Data are presented as mean ± SEM.
∗p < 0.05, ∗∗p < 0.01. (I) Representative TUNEL-labeled cryosections of P17 RA and OIR mice and cryosections of mice intravitreally injected with bovine serum
albumin derivate DQ-BSA and co stained with anti-LC3B (green). Arrows are indicating DQ-BSA staining in ECs. Scale bar: 50 µm. ILM, inner limiting membrane;
GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer; NV, neovascularization.
To determine the effect of anti-VEGF treatment on the
autophagic process in the OIR mouse model we first examined
the classical autophagy markers by Western blot assays.
Quantitative analysis revealed a slight but significantly increase
in LC3B II levels at P17 OIR (Figures 5E,F). This increase was
corroborated by immunofluorescence assays where LC3B was
detected mainly in GCL and INL (Figure 5G). These findings
demonstrated that targeting VEGF prevented vascular alterations
and also increased the autophagic flux in P17 OIR retinas.
Spautin-1 Inhibited Autophagy, Reduced
NV but Did Not Prevented
Neurodegeneration in the OIR Mouse
Model
As autophagy seemed a key feature during NV, we next decided
to decrease the autophagy flux by a single administration of
Spautin-1 at P12 and to evaluate vascular, neuronal, and glial
parameters at P17 and P26, respectively (Figure 6A). Western
blot analysis showed a significant decrease in LC3B II expression
at P13 (Figure 6B). Quantitative analysis of flat-mounts labeled
with GSA-IB4 lectin showed a significant reduction of more than
70% in neovascular area after Spautin-1 treatment. However,
other vascular alterations did not improved in OIR Spautin-1
mice, suggesting that autophagy is important for NV and that
the activation in the OIR mouse is not mediating physiological
revascularization (Figures 6C,D). In addition, a slight decrease
in NG-2 staining was observed in Spautin-1 mice at P17
OIR (Figure 6E).
After Spautin-1 or vehicle treatment, no changes in GFAP
levels were detected by Western blot of neural retinas samples
(Figures 7A,B) or in flat-mount of retinas (Figure 7C). Similarly,
no statistically differences in the expression of GS protein were
found by Western blot (Figures 7A,B) or immunofluorescence
(Figure 7D) after Spautin-1 treatment neither at P17 nor at P26.
In regard to neuronal functionality, the amplitude of the
a-wave showed a tendency to decrease in OIR Spautin-1 mice
at P17. In accordance, a later response (increased latency) was
detected in photoreceptors as well as in inner neurons after
autophagy inhibition (Figure 7E). Quantitative analysis of a-wave
and b-wave amplitudes and latencies evidence no significant
changes in neuronal functionality at P26. In line with these
results, TUNEL staining showed a slight increase in the number
of positive cells in the ONL after Spautin-1 treatment at P17 OIR
(Figure 7F). Activation of apoptosis, measured by a reduction
in total caspase 3 protein levels was not significantly different at
both time points evaluated (Figures 7G,H). Finally, we evaluated
protein expression of LC3B and p62 5 days (P17) or 14 days
(P26) after Spautin-1 treatment. Quantitative analysis of Western
blot assays (Figures 7G,H) and confocal microscopy images
(Figure 7I) evidenced that both autophagy markers returned to
OIR levels. These results showed that the inhibition of autophagy
by Spautin-1 was harmful for the functionality and survival of
photoreceptors in P17 OIR retinas.
DISCUSSION
Preretinal NV is a common feature in many diseases, including
ROP, DR and Sickle cell retinopathy. Even though their
pathophysiology is different, this family of retinopathies is
characterized by the decrease in oxygen tension at a certain
stage. The immediate response is the increase in VEGF synthesis,
a trophic factor responsible of the proliferation of ECs that
originate fragile and immature vascular tufts (Campochiaro,
2015; Rubio and Adamis, 2016). Simultaneously, other events
take place in the retina as gliosis and neurodegeneration,
which can be developed by the hypoxic stimulus or another
primary injury (Ridano et al., 2017). Coincidentally, proliferative
retinopathies treatments are palliative and aim to manage NV.
However, ongoing inflammation, neuronal death, and impaired
oxygen supply frequently lead to neovascular recurrence.
Thus, previous studies indicated that a more appropriate
therapy should encompass the normalization of both vascular
and non-vascular alterations in proliferative retinopathies
(Liang et al., 2012).
Modulation of autophagy flux results an attractive target,
as this intracellular process occurs in every cell and has
proven relationship with neurodegeneration, angiogenesis, and
inflammation (Boya et al., 2016). Several research studies have
demonstrated that inhibition or stimulation of the autophagic
flux is able to reverse the alterations of multiple chronic
or acute pathologies, including visual disturbances (Mitter
et al., 2012; Russo et al., 2013; Chinskey et al., 2014;
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FIGURE 3 | Effect of Rapamycin on the vascular alterations in the OIR mouse retinas. (A) Rapamycin treatment schedule. Rapamycin (0,5 µg/ml) or vehicle was
intravitreally injected at P12 and evaluated at P13, P17, or P26 after 4 h of CQ administration. (B) Representative Western blot and quantification data of autophagy
markers, LC3B II and p62, from neural retinal extracts of OIR mice intravitreally injected with vehicle or Rapamycin at P12 and evaluated at P13, 4 h after CQ
administration. β-Actin is shown as a loading control. Graph shows results of three independent experiments. (C) Representative images of flat-mount retinas at P17
showing GSA-IB4 vascular staining in OIR-vehicle and OIR-Rapamycin mice. Areas with VO and NV are indicated. Scale bar: 500 µm. (D) The VO (%) was quantified
as the ratio of central avascular area to whole retinal area, the NV (%) was quantified as a percentage of whole retinal area. In mayor vessels of the retina, diameter
was quantified by tracing a transversal line to the vessel. The tortuosity was obtained by drawing a line along the vessel and comparing it to a straight line traced
from the optic nerve to the first branching point. (E) Representative Western blot and quantification data of VEGF from neural retinal extracts in OIR mice intravitreally
injected with vehicle or Rapamycin at P12 and evaluated at P17, 4 h after CQ administration. β-Actin is shown as a loading control. Graph shows results of three
independent experiments. (F) Representative immunofluorescence analysis of NG-2 (green) in cryosections of OIR mice intravitreally injected with vehicle or
Rapamycin at P12 and evaluated at P17, 4 h after CQ administration. Scale bar: 50 µm. ILM, inner limiting membrane; GCL, ganglion cell layer; IPL, inner plexiform
layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer. Data are presented as mean ± SEM. ∗p < 0.05, ∗∗p < 0.01.
Frost et al., 2014; Chai et al., 2016; Rosa et al., 2016; Amato
et al., 2018). Rapamycin, rapalogs and CQ are the most habitual
choice for experimental design as they have been approved by
FDA for a specific treatment (Nalbandian et al., 2015; Kezic et al.,
2018) and it would be easier to execute clinical trials for second
uses of these drugs.
Therefore, we initially explored changes in the autophagy
flux in the OIR mouse model. To note, OIR model very closely
recapitulates the pathologic events occurring in ROP and some
aspects of proliferative DR (Smith et al., 1994). Treatments
were carried out at different postnatal days when pups were still
in developmental phase, where autophagy plays a crucial role
(Boya et al., 2016). Indeed, Western blot assays in RA showed
a decrease of LC3B II and p62 protein levels from P12 to P26,
indicating a high autophagy flux early after birth. In contrast,
OIR mice showed an increase in LC3B II and p62 protein levels
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FIGURE 4 | Continued
Frontiers in Cellular Neuroscience | www.frontiersin.org 11 June 2019 | Volume 13 | Article 279
fncel-13-00279 June 26, 2019 Time: 16:9 # 12
Subirada et al. Autophagy Modulators in the OIR Mouse Model
FIGURE 4 | Effect of Rapamycin on the glial reactivity, neuronal functionality, and autophagy markers in OIR mouse retinas. (A) Representative Western blot of GS
and GFAP from neural retina extracts of OIR mice intravitreally injected with vehicle or Rapamycin at P12 and evaluated at P17, 4 h after CQ administration. β-Actin
is shown as a loading control. (B) Levels of GS and GFAP were quantified by densitometry and normalized to β-actin. Graph shows results of three independent
experiments. (C) Representative images of flat-mount retinas at P17 showing GFAP staining in OIR-vehicle and OIR-Rapamycin mice. Scale bar: 500 µm.
(D) Representative immunofluorescence analysis of GS (green) in cryosections of OIR mice intravitreally injected with vehicle or Rapamycin at P12 and evaluated at
P17, 4 h after CQ administration. Scale bar: 50 µm. (E) Amplitudes and latencies of a- and b-waves from scotopic ERG were recorded at P17 and P26 in RA and
OIR mice injected at P12 with vehicle or Rapamycin. Data show the average of responses of both eyes with eight mice per condition. (F) Representative
TUNEL-labeled cryosections of RA and OIR mice injected with vehicle or Rapamycin at P12 and evaluated at P17 and P26. Scale bar: 50 µm. (G,H) Representative
Western blot and quantification data of total caspase-3, LC3B II and p62 from neural retina samples of OIR mice intravitreally injected with vehicle or Rapamycin at
P12 and evaluated at P17 and P26, 4 h after CQ administration. β-Actin is shown as a loading control. Graph shows results of three independent experiments.
(I) Representative immunofluorescence analysis of LC3B (green) and p62 (red) in cryosections of OIR mice intravitreally injected with vehicle or Rapamycin at P12
and evaluated at P17 and P26, 4 h after CQ administration. Cell nuclei were counterstained with Hoechst 33258 (blue). Scale bar: 50 µm. ILM, inner limiting
membrane; GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer. Data are presented as
mean ± SEM. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
FIGURE 5 | Effect of Anti-VEGF treatment on autophagy markers in the OIR mouse retinas. (A) Anti-VEGF mAb treatment schedule. Anti-VEGF mAb (1.25 µg) or
vehicle was intravitreally injected at P12 and evaluated a P17 or P26, 4 h after CQ administration. (B) Representative images of flat-mount retinas at P17 OIR
showing GSA-IB4 vascular staining in vehicle or anti-VEGF-injected eyes. Areas with VO and NV are indicated. Scale bar: 500 µm. (C) Representative Western blot
of VEGF from P17 neural retinal extracts of OIR mice injected at P12 with vehicle or anti-VEGF mAb. β-Actin is shown as a loading control. (D) Levels of VEGF were
quantified by densitometry and normalized to β-actin. Graph shows results of three independent experiments. (E) Representative Western blot of LC3B II and p62
from neural retina extracts of OIR mice intravitreally injected with vehicle or anti-VEGF mAb at P12 and evaluated at P17 and P26, 4 h after CQ administration.
β-Actin is shown as a loading control. (F) Levels of LC3B II and p62 were quantified by densitometry and normalized to β-actin. Graph shows results of four
independent experiments. (G) Representative immunofluorescence analysis of LC3B (green) and p62 (red) in cryosections of OIR mice intravitreally injected with
vehicle or anti-VEGF mAb at P12 and evaluated at P17, 4 h after CQ administration. Cell nuclei were counterstained with Hoechst 33258 (blue). Scale bar: 50 µm.
ILM, inner limiting membrane; GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer. Data
are presented as mean ± SEM. ∗∗p < 0.01.
at P17 OIR, compared to RA controls demonstrating a rise in
autophagosomes in the cytosol of retinal cells. Transcriptional
activity of autophagy proteins revealed a significant increase in
p62 mRNA levels at P17OIR. Upon induction of the flux, p62
is degraded into the autophagosome and it would be necessary
to synthesize more protein. This result would indicate that the
increase in p62 protein levels at this time point is a consequence
of the increased protein synthesis but not of its accumulation.
Physiological vascularization of the retina completes at P21
in mice, when the provisional hyaloid vasculature is replaced
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FIGURE 6 | Effect of the Spautin-1 on the NV in OIR mouse retinas. (A) Spautin-1 treatment schedule. Spautin-1 (200 µM) or vehicle was intravitreally injected at
P12 and evaluated at P17 or P26, 4 h after of CQ administration. (B) Representative Western blot and quantification data of autophagy marker LC3B II from neural
retinal extracts of OIR mice intravitreally injected with Spautin-1 or vehicle at P12 and evaluated at P13, 4 h after CQ administration. β-Actin is shown as a loading
control. Graph shows results of three independent experiments. (C) Representative images of flat-mount retinas at P17 showing GSA-IB4 vascular staining in
OIR-vehicle and OIR-Spautin-1 mice. Areas with VO and NV are indicated. Scale bar: 500 µm. (D) The VO (%) was quantified as the ratio of central avascular area to
whole retinal area, the NV (%) was quantified as a percentage of whole retinal area. In mayor vessels of the retina, diameter was quantified by tracing a transversal
line to the vessel. The tortuosity was obtained by drawing a line along the vessel and comparing it to a straight line traced from the optic nerve to the first branching
point. (E) Representative immunofluorescence analysis of NG-2 (green) in cryosections of OIR mice intravitreally injected with vehicle or Spautin-1 at P12 and
evaluated at P17, 4 h after CQ administration. Scale bar: 50 µm. ILM, inner limiting membrane; GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear
layer; OPL, outer plexiform layer; ONL, outer nuclear layer. Data are presented as mean ± SEM. ∗p < 0.05, ∗∗p < 0.01.
by the definite one following a hypoxic gradient. Firstly, the
superficial plexus is formed by the radial sprouting of vessels from
the optic nerve. Later, the deep plexus is formed by transversal
outgrowth of superficial vessels and the retinal vasculature
achieves completion with the formation of the intermediate
plexus (Stahl et al., 2010). Due to the fact that there is an irregular
oxygen supply in the different layers of the retina, the sensing
of the hypoxic stimulus could vary along the neural retina and
therefore the cellular response (Rodrigues et al., 2013). Confocal
images showed that areas near the vascular plexus, GCs and
neurons residing in the INL increased LC3B protein expression
in P17 OIR mice, whereas autophagy markers were not modified
in ONL neurons. Unchanged autophagic flux in photoreceptors
could be explained by the provision of oxygen by the choroid
vasculature to rods and cones, preventing severe hypoxia in this
layer. Although photoreceptors are damaged in OIR model, a
reduced cell death rate is observed (Ridano et al., 2017). Nearby
to the ILM, both MGCs and ECs showed an increase in LC3B
staining. Interestingly, at P17 OIR, LC3B-positive vesicles were
found inside ECs in neovascular tufts, suggesting an increased
autophagic flux in proliferating cells.
We further confirmed the activation in autophagy flux at P17
OIR by observing a greater number of LC3B/LAMP1 double
labeled vesicles, indicating an increase in amphisomes in the
inner layers of the retina compared to control mice. An increase
in LAMP1 structures was observed after blockade of the flux with
CQ, mainly in the ILM, evidencing that the degradation pathway
is activated. In addition, neovessels in the ILM hydrolyzed DQ-
BSA in lysosomes in great proportion. By TUNEL assay, we
demonstrate that cell viability is reduced in INL and GCL. Indeed,
neurons undergoing cell death or high hypoxic stress could
activate autophagy flux as a survival mechanism.
Next we wonder if the administration of Rapamycin at P12
could improve vascular, glial, or neuronal alterations in OIR
mice. We took into account that mTORC1 inhibition increases
autophagy flux, but also modulates multiple intracellular
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FIGURE 7 | (A) Effect of Spautin-1 on the glial reactivity, neuronal functionality and autophagy markers in OIR mouse retinas. Representative Western blot of GFAP
and GS from neural retina extracts of OIR mice intravitreally injected with Spautin-1 or vehicle at P12 and evaluated at P17, 4 h after CQ treatment. β-Actin is shown
as a loading control. (B) Levels of GFAP and GS were quantified by densitometry and normalized to β-actin. Graph shows results of four independent experiments.
(C) Representative images of flat-mount retinas at P17 showing GFAP staining in OIR-vehicle and OIR-Spautin-1 mice. Scale bar: 500 µm. (D) Representative
immunofluorescence analysis of GS (green) in cryosections of OIR mice intravitreally injected with vehicle or Spautin-1 at P12 and evaluated at P17, 4 h after CQ
administration. Scale bar: 50 µm. (E) Amplitudes and latencies of a- and b-waves from scotopic ERG were recorded at P17 and P26 in RA and OIR mice injected at
P12 with vehicle or Spautin-1. Data show the average of responses in both eyes with eight mice per condition. (F) Representative TUNEL-labeled cryosections of RA
and OIR mice injected with vehicle or Spautin-1 at P12 and evaluated at P17 and P26. Scale bar: 50 µm. (G,H) Representative Western blot and quantification data
of total caspase-3, LC3B II and p62 from neural retina samples of OIR mice intravitreally injected with vehicle or Spautin-1 at P12 and evaluated at P17 and P26, 4 h
after CQ administration. β-Actin is shown as a loading control. Graph shows results of three independent experiments. (I) Representative immunofluorescence
analysis of LC3B (green) and p62 (red) in cryosections of OIR mice intravitreally injected with vehicle or Spautin-1 at P12 and evaluated at P17 and P26, 4 h after CQ
administration. Cell nuclei were counterstained with Hoechst 33258 (blue). Scale bar: 50 µm. ILM, inner limiting membrane; GCL, ganglion cell layer; IPL, inner
plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer. Data are presented as mean ± SEM. ns, non-significant, ∗p < 0.05,
∗∗p < 0.01, ∗∗∗p < 0.001.
pathways related to inflammation, angiogenesis and metabolism.
A single intraocular injection of Rapamycin decreased the
area occupied by neovessels, however the treatment did not
promote physiological revascularization (evaluated by avascular
area, vessel dilatation, and tortuosity). The normalization of
the vascular plexus is essential for the proper irrigation of the
retinal tissue and prevents future alterations derived from the
turbulence in the blood flow or stasis of blood cells (Liang et al.,
2012). The reduction in NV area was supported by the decrease
in VEGF levels. It has been described that inhibition of mTORC1
decreases the synthesis of the transcription factor HIF-1α and
consequently downregulates the expression of its target genes
(Liu et al., 2015). Notably, in the retina VEGF is produced mainly
in MGCs, astrocytes, GCs, retinal pigmented epithelium and ECs
in a minor proportion (Wang et al., 2010). Then, it is possible that
the modulation of the neovascular process is due to the direct
effect of Rapamycin on other cells rather than endothelium.
In fact, Rapamycin could be a more successful therapeutic
strategy because it decreases the synthesis of VEGF, providing an
adequate level of the trophic factor. The excessive inhibition of
VEGF signaling would be detrimental for neurons. Under certain
pathological conditions, increased autophagy flux can also
induce cell death (Hirt et al., 2018). In our model, Rapamycin
did not alter pericytes viability, one of the most susceptive cells
in the vasculature. Persistence of mural cells is a good marker of
vascular maturation, indicating that final stage of vasculogenesis
is not altered and the newly formed vessels are functional.
Related to gliosis, Rapamycin markedly reduced GFAP
expression at P26 OIR, indicating a decrease in the glial response
during the neovascular regression stage. This would contribute
to the reduction in the persistent pro-inflammatory response
that promotes damage in the retinal tissue. Unfortunately,
a single dose of Rapamycin was insufficient to increase
neuronal functionality. Further studies would be necessary
to evaluate if a prolonged administration schedule improves
visual function.
Previously, it has been reported that high dose of Rapamycin
increases the avascular area (Yagasaki et al., 2014) which could
be a result of reduced proliferation or increased cell death of
ECs. Here, the induction in autophagy flux did not resulted in
an increase of apoptosis, measured by total caspase 3, suggesting
that the crosstalk between both pathways is not the responsible
of the caspase mediated cell death. Our results showed that the
increase in autophagy flux continue up to P17 OIR, indicating
that Rapamycin has a relatively long half-life in the vitreous, as
previously reported (Nguyen et al., 2018).
In a comparative experiment, we analyzed the effect of
the anti-VEGF therapy on the autophagy flux. Western blot
analysis revealed a slight induction of the flux at P17 OIR.
As confocal images showed an increase in the autophagy
proteins, LC3B and p62, in GCL and INL, we consider
that the deprivation of the trophic factor VEGF can activate
survival mechanisms as autophagy. Previously, we reported
that intravitreal administration of anti-VEGF does not improve
neuronal functionality and gliosis (Ridano et al., 2017). Thereby,
Rapamycin benefits over anti-VEGF therapy rely on the
multiplicity of events modulated through the inhibition of
mTORC1. Although both treatments reduced NV and activated
autophagy, neither of them prevented neurodegeneration in our
experimental conditions.
To unravel the role of autophagy in the OIR mouse model,
we injected at P12 a single dose of Spautin-1, an inhibitor of
the ubiquitin-specific peptidases USP10 and USP13, which target
the Beclin-1 subunit of Vps34 complexes (Liu et al., 2011).
Remarkably, vascular effects were similar to those observed with
Rapamycin. Spautin-1 decreased the neovascular area without
modifying other vascular parameters. In this sense, confocal
images of neovessels shed light on this result demonstrating that
proliferating ECs, highly metabolic cells, showed a fast autophagy
flux. Thus, the inhibition of this process would lead to vascular
death or a decreased proliferation rate. The interaction between
ECs and pericytes is critical for the formation of a structurally
sound microvasculature. In this study, we found a reduced NG-2
staining in OIR mice retinas after Spautin-1 treatment indicating
an apparent decrease in pericyte density, which may exacerbate
vascular alterations.
In regard to non-vascular cells, glial response remained
unchanged as no modifications in GS and GFAP levels were
detected after Spautin-1 treatment. Electroretinographic
recording showed that photoreceptors functionality tend to
decrease at P17 OIR in Spautin-1 treated mice. This result
reinforces the idea that retinal layers with high autophagy flux
at the neovascular peak activate this pathway as a survival
mechanism. In this sense, the importance of the autophagic flow
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became more evident in the photoreceptors because it is the layer
less affected in the OIR. Correlatively, an increase in TUNEL
positive staining was observed in the ONL when autophagy was
inhibited. Five days after Spautin-1 injection, LC3B II and p62
protein levels returned to OIR control levels, indicating a reduced
half-life of the drug in the eye.
Presumably, all retinal cells are intended to activate autophagy
flux in hypoxic conditions. However, the ability to respond will
depend on the status of the cell as well as the intensity and
duration of the stimuli (Boya et al., 2016). Prior to the hypoxic
stage in the OIR model, the hyperoxic phase induces several
alterations in retinal cells originated by apoptotic events at P12
(Sennlaub et al., 2002; Vecino et al., 2004; Narayanan et al., 2011).
Recently, it has been demonstrated that retinas of OIR mice are
characterized by increased apoptosis and decreased autophagy
from P13 to P15 (Cammalleri et al., 2017). Here, using the same
in vivo model, we completed the analysis including, in addition
to P12 and P17, the vascular regression stage (P26). Overall, our
results demonstrate that all treatments of induction or inhibition
of the autophagic flux reduced neovascular area but were unable
to completely reverse the neuronal damage. Besides, compared
to current treatments, rapamycin provides a more promising
therapeutic strategy as it reduces both neovascular tufts and
persistent gliosis.
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